Drug shortages

Ceftriaxone Sodium Injection

Baxter Healthcare

To Be Discontinued0338-5002-41Anti-Infective
Open FDA's page for this record
Discontinued date
10/30/2026
Update type
New
Initial posting date
10/30/2026
Package NDC
0338-5002-41
Generic name
Ceftriaxone Sodium Injection
Contact info
888-229-0001
Related info
Discontinuation of the manufacture of the drug
Update date
10/30/2026
Dosage form
Injection
Presentation
Ceftriaxone Sodium in Plastic Container, Injection, 1g/50mL (NDC 0338-5002-41)
Company name
Baxter Healthcare
Status
To Be Discontinued
Therapeutic category
Anti-Infective
Harmonized identifiers (openFDA)
Application number
ANDA065224
Brand name
CEFTRIAXONE
Generic name
CEFTRIAXONE SODIUM
Manufacturer name
Baxter Healthcare Company
Product NDC
0338-5002, 0338-5003
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRAVENOUS
Substance name
CEFTRIAXONE SODIUM
RxCUI
1665021, 1665046
SPL ID
e6debc12-1f25-437c-970e-607f4953c7f7
SPL set ID
4c5c2d3f-5038-41a1-a2fe-4dcd048dbac1
Package NDC
0338-5002-41, 0338-5003-41
UNII
023Z5BR09K
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.